News from skyhawk therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 05, 2020, 09:00 ET Skyhawk Therapeutics Expands Leadership Team with Chief Medical Officer and Head of Chemistry, and adds to its Scientific Advisory Board

Skyhawk Therapeutics today announced that Dr. Elliot Ehrich has joined the Company as Chief Medical Officer and Dr. Joseph Duffy has joined as Senior ...


May 12, 2020, 08:00 ET Skyhawk Therapeutics Announces Expansion of its Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA Splicing

Skyhawk Therapeutics, Inc. ("Skyhawk") today announced that it has expanded its strategic collaboration with Merck, known as MSD outside the United...


Feb 24, 2020, 10:55 ET Experienced Business Leader in Biopharmaceutical Industry Joins as Chief Operating Officer at Skyhawk Therapeutics

Skyhawk Therapeutics, Inc. ("Skyhawk" or the "Company") today announced Dr. Terrance ("Terry") Connolly will become its Chief Operating Officer. Dr....


Nov 12, 2019, 09:00 ET Skyhawk Therapeutics Announces a Second Multi-Target Collaboration Agreement with Celgene to Discover and Develop Novel Small Molecules that Modulate RNA Splicing

Skyhawk Therapeutics, Inc. (Skyhawk) today announced that it has entered into a second global strategic collaboration with an affiliate of Celgene...


Oct 15, 2019, 07:30 ET World Renowned Experts Appointed to Skyhawk Therapeutics Scientific Advisory Board

Skyhawk Therapeutics, Inc. ("Skyhawk"), a drug discovery and development company focused on revolutionizing disease treatment with small molecules...


Sep 04, 2019, 10:07 ET RNA Expert Dr. Phillip Sharp Joins as Advisor to Skyhawk Therapeutics

Skyhawk Therapeutics, Inc. ("Skyhawk"), today announced Dr. Phillip Sharp has joined as special advisor to its Scientific Advisory Board. Dr. Sharp's ...


Jul 16, 2019, 08:00 ET Skyhawk Therapeutics Announces Agreement with Genentech to Discover and Develop Small Molecule RNA Splicing Modifiers for Oncology and Neurodegenerative Diseases

Skyhawk Therapeutics, Inc. (Skyhawk) today announced that it has entered into a multi-target exclusive option and license agreement with Genentech, a ...


Jul 08, 2019, 07:30 ET Skyhawk Therapeutics Announces Expansion of Collaboration Agreement with Biogen

Skyhawk Therapeutics, Inc. ("Skyhawk") today announced the expansion of its collaboration with Biogen, originally announced January 4, 2019. The...


Jul 08, 2019, 07:30 ET Skyhawk Therapeutics Announces Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA Splicing

Skyhawk Therapeutics, Inc. (Skyhawk) today announced that it has entered a strategic collaboration with Merck, known as MSD outside the United States ...


Jul 08, 2019, 07:15 ET Skyhawk Therapeutics Announces Addition of World Leading SAB Head & New VP of Oncology Biology

Skyhawk Therapeutics, Inc. ("Skyhawk") today announced that Dr. Tyler Jacks has joined the company as head of its Scientific Advisory Board, and Dr....


May 06, 2019, 09:19 ET Skyhawk Therapeutics Announces Agreement with Takeda to Develop Novel Small Molecule RNA Splicing Modifiers for Neurodegenerative Diseases

Skyhawk Therapeutics, Inc. (Skyhawk) today announced a strategic collaboration with Takeda Pharmaceutical Company Limited (Takeda) in which Skyhawk...


Feb 12, 2019, 13:17 ET Pioneer in Taking RNA Therpeutics Through the Clinic Joins Skyhawk Therapeutics as Chief Medical Officer

Skyhawk Therapeutics, Inc. ("Skyhawk"), today announced Dr. Roberto Guerciolini has joined the company as its Chief Medical Officer. Dr. Guerciolini...


Jan 04, 2019, 07:31 ET Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets

Biogen Inc (Nasdaq: BIIB) and Skyhawk Therapeutics, Inc. (Skyhawk) today announced a strategic collaboration in which the companies will leverage...


Jun 26, 2018, 09:16 ET Skyhawk Therapeutics anuncia colaboración con Celgene para desarrollar modificadores de empalme de ARNm mediante STAR*

- Skyhawk Therapeutics anuncia una colaboración estratégica con Celgene para descubrir y desarrollar innovadores modificadores de empalme de ARNm...


Jun 26, 2018, 08:48 ET Skyhawk Therapeutics gibt strategische Kooperation mit Celgene zur Entdeckung und Entwicklung neuartiger mRNA-Splicing-Modifier mithilfe der STAR* Technologie-Plattform von Skyhawk bekannt

Skyhawk Therapeutics, Inc. („Skyhawk") gab heute eine globale strategische Kooperation mit einer Tochtergesellschaft der Celgene Corporation...


Jun 26, 2018, 08:18 ET Skyhawk Therapeutics annonce une collaboration stratégique avec Celgene pour la découverte et le développement de modificateurs novateurs de l'épissage de l'ARNm, au moyen de la plateforme technologique STAR* de Skyhawk

Skyhawk Therapeutics, Inc. (« Skyhawk ») a annoncé aujourd'hui une collaboration stratégique mondiale avec une filiale de Celgene Corporation («...


Jun 26, 2018, 07:31 ET Skyhawk Therapeutics schließt Equity-Investment-Runde in Höhe von 40 Millionen US-Dollar ab

Skyhawk Therapeutics, Inc. („Skyhawk"), gab heute, zusätzlich zur kürzlich angekündigten strategischen Zusammenarbeit im Volumen von 60 Millionen...


Jun 26, 2018, 07:31 ET Skyhawk Therapeutics anuncia una ronda de inversión de $40 millones

Skyhawk Therapeutics, Inc. ("Skyhawk"), anunció hoy el cierre de la ronda de inversión de capital de $40 millones además de una colaboración...


Jun 26, 2018, 07:31 ET Skyhawk Therapeutics annonce une ronde d'investissement en actions de 40 millions USD

Skyhawk Therapeutics, Inc. (« Skyhawk »), a annoncé aujourd'hui la clôture d'une nouvelle ronde d'investissement en actions de 40 millions USD, en...


Jun 26, 2018, 07:31 ET Skyhawk Therapeutics Announces $40 Million Equity Investment Round

Skyhawk Therapeutics, Inc. ("Skyhawk"), today announced the closing of a new $40 million equity investment round alongside its recently announced $60 ...


Jun 26, 2018, 07:30 ET Skyhawk Therapeutics Announces Strategic Collaboration with Celgene to Discover and Develop Novel mRNA Splicing Modifiers using Skyhawk's STAR* Technology Platform

Skyhawk Therapeutics, Inc. ("Skyhawk"), today announced a global strategic collaboration with a Celgene Corporation affiliate ("Celgene") to...